Cabo Verde vs Indonesia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Cabo Verde
0.7%
in 2024
Indonesia
0.7%
in 2024
Cabo Verde rank
51st
Indonesia rank
51st
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Cabo Verde
- Indonesia
How they compare
Cabo Verde currently reports 0.7% against 0.7% in Indonesia, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Indonesia ahead.
Cabo Verde ranks 51st and Indonesia ranks 51st of 247 countries.
Indonesia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cabo Verde | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.8% | 0.9% | 0.1% | Indonesia |
| 2020s | 0.6% | 0.8% | 0.2% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Cabo Verde or Indonesia?
- Cabo Verde, at 0.7% against 0.7% in Indonesia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Cabo Verde and Indonesia?
- 0.0%, with Cabo Verde ahead.
- How many years of comparable data are there for Cabo Verde and Indonesia?
- 10 years are reported by both, from 2015 to 2024.
- How do Cabo Verde and Indonesia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Cabo Verde ranks 51st and Indonesia ranks 51st of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.